9888À­Ë¹Î¬¼Ó˹

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÎÒÃǵķþÎñ

×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕߣ¬CTI9888À­Ë¹Î¬¼Ó˹¼ì²âΪȫÇò¿Í»§ÌṩһվʽĥÁ·¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°ÊÖÒÕ·þÎñ¡£

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÐÐÒµ½â¾ö¼Æ»®

·þÎñÄÜÁ¦ÒÑÖÜÈ«ÁýÕÖµ½·ÄÖ¯´ò°ç¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉúÑÄ¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§¿µ½¡¡¢Ê³Îï¼°Å©²úÆ·……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÌØÉ«·þÎñ

ÖÜÈ«°ü¹ÜÆ·ÖÊÓëÇå¾²£¬Íƶ¯ºÏ¹æÓëÁ¢Ò죬ÕÃÏÔÆ·ÅƾºÕùÁ¦£¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü¿µ½¡¡¢¸üÇå¾²¡¢¸üÂÌÉ«µÄ¿ÉÒ»Á¬Éú³¤¡£

¼ÓÈëÎÒÃÇ
È˲ÅÕþ²ß
ÕÐÏÍÄÉÊ¿
9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
È˲ÅÕþ²ß
°ü¹ÜÔ±¹¤»ù±¾È¨ÒæÓ븣Àû £»ÌṩרҵÊÖÒÕÅàѵ£¬Ôö½øÔ±¹¤Éú³¤ £»¿ªÕ¹¸»ºñ¶à²ÊµÄ»î¶¯£¬Æ½ºâÔ±¹¤ÊÂÇéÓëÉúÑÄ¡£
9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÕÐÏÍÄÉÊ¿
½Ó´ý¼ÓÈë9888À­Ë¹Î¬¼Ó˹¼ì²â¸÷ÈËÍ¥£¬ÎÒÃǽ«ÎªÄã´î½¨Ò»¸ö³ä·ÖÑéÕ¹²Å»ª£¬ÊµÏÖÖ°ÒµÀíÏëµÄÎę̀¡£
9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÐÂÎÅ×ÊѶ

¸¾¿ÆÉúÖ³Àಡԭ΢ÉúÎï°ÐÏò¼ì²â£¨tNGS£©£º½ô¸úר¼Ò¹²Ê¶£¬¸üÖÜÈ«ÖúÁ¦¹¬¾±°©É¸²é

Ðû²¼Ê±¼ä£º2024-01-12 ä¯ÀÀ´ÎÊý£º4066

       ¹¬¾±°©(cervical cancer)Ò²³Æ×Ó¹¬¾±°©£¬Ö¸±¬·¢ÔÚ×Ó¹¬ÒõµÀ²¿¼°¹¬¾±¹ÜµÄ¶ñÐÔÖ×Áö£¬ÊÇÅ®ÐÔ³£¼û¶ñÐÔÖ×ÁöÖ®Ò»£¬·¢²¡ÂÊλÓÚÅ®ÐÔÖ×ÁöµÄµÚ¶þλ¡£È«ÌìÏÂÿÄêԼĪÓÐ20Íò¸¾Å®ËÀÓÚÕâÖÖ¼²²¡¡£

 

        ¹¬¾±°©²¡ÒòÃ÷È·£¬ÏÕЩ100%µÄ¹¬¾±°©ÓÉÈËÈéÍ·×´Áö²¡¶¾£¨HPV£©Ñ¬È¾ÒýÆð£¬·ÀÖεÄÒªº¦ÔÚÓÚ£º°´ÆÚ¾ÙÐи¾¿Æ¼ì²é£¬ÊµÊ±·¢Ã÷ºÍÖÎÁƹ¬¾±°©Ç°²¡±ä£¬ÖÕÖ¹ÆäÏò¹¬¾±°©µÄÉú³¤¡£

 

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾

ͼƬȪԴ£ºCells 2019, 8, 622; doi:10.3390/cells8060622

 

Ò»¡¢HPV·ÖÐÍ

        HPVѬȾ¹¬¾±ÉÏÆ¤ºó£¬ÒòÆä»ùÒòÐͱð²î±ð¡¢ÊÇ·ñÒ»Á¬Ñ¬È¾¼°Ò»Á¬Ñ¬È¾Ê±¼ä²î±ð£¬ÆäÖ²¡Î£º¦Ò²ÏÔÖø²î±ð¡£Òò´Ë£¬¶Ô HPV¾ÙÐзÖÐͼì²â²¢Ã÷È·ÊÇ·ñ±£´æÒ»Á¬Ñ¬È¾¾ßÓÐÖ÷ÒªµÄÁÙ´²ÒâÒå¡£

 

        HPV»ùÒò×éÐòÁб£´æ10%ÒÔÉϵIJî±ð£¬¼´Îª²î±ðµÄ»ùÒòÐͱð¡£ÏÖÔÚÒÑ·¢Ã÷²¢ÊèÉ¢Åжϳö 200¶àÖÖHPVÐͱ𣬲¢°´ÆäÓÕ·¢°©Ö¢µÄDZÁ¦£¬·ÖΪ¸ßΣÐÍÓëµÍΣÐÍ¡£·ÖÐÍÇéÐÎÈçϱíËùʾ£º

 

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾

 

¶þ¡¢×¨¼Ò¹²Ê¶ÍƼö¼ì²â

        ¡¶ÈËÈéÍ·×´Áö²¡¶¾ºËËá¼ì²âÓÃÓÚ¹¬¾±°©É¸²éÖйúר¼Ò¹²Ê¶£¨2022£©¡·£¬ÍƼö½«HPVºËËá¼ì²â×÷ΪÎÒ¹ú¹¬¾±°©É¸²éµÄÖ÷ÒªÒªÁì¡£

 

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾

ͼƬȪԴ£ºÍøÂç


 

“¹²Ê¶”Ìá³öÒÔÏÂÍÆ¼öÒâ¼û£º

        ÍÆ¼öÒâ¼û2£ºHPVºËËá¼ì²âÒªÁì¿ÉÒÔ·ÖΪ·ÇÀ©Ôö·¨ºÍÀ©Ôö·¨£¬ÕâЩҪÁì¿É¶ÔHPVÈ«»ùÒò×é»òijһƬ¶Ï¾ÙÐÐÓÐÓüì²â¡£

 

        ƾ֤ÊÇ·ñ¶ÔÄ¿µÄ»ùÒò¾ÙÐÐÀ©Ôö£¬HPVºËËá¼ì²âÒªÁì¿ÉÒÔ·ÖΪÀ©Ôö·¨ºÍ·ÇÀ©Ôö·¨¡£ÏÖÔÚ£¬ÎÒ¹úHPVºËËá¼ì²â³£ÓÃÊÖÒÕ¶àÒÔºËËáÀ©Ôö·¨¼°ÆäÑÜÍâÐÐÒÕΪÖ÷£¬°üÀ¨£ººãÎÂÀ©Ôö·¨¡¢Ó«¹â PCR£¨PCR?Ó«¹â̽Õë·¨£©¡¢PCR?ëϸ¹ÜµçÓ¾·¨¡¢ PCR?΢Á÷¿ØÐ¾Æ¬·¨¡¢PCR?ÈÜ»¯ÇúÏß·¨¡¢PCR?·´ÏòµãÔÓ½»/Á÷ʽӫ¹âÔÓ½»·¨µÈ¡£

 

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾

ͼƬȪԴ£ºÖлªÒ½Ñ§ÔÓÖ¾, 2023,103(16) : 1184-1195.

 

Èý¡¢¸¾¿ÆÉúÖ³Àಡԭ΢ÉúÎï°ÐÏò¼ì²â£¨tNGS£©

        ÎÒÃÇÈ«ÐÂÍÆ³ö¸¾¿ÆÉúÖ³Àಡԭ΢ÉúÎï°ÐÏò¼ì²â£¨tNGS£©£¬½ô¿Ûר¼Ò¹²Ê¶ÍƼöµÄ¼ì²âÒªÁ죬Õë¶Ô¸¾¿ÆÉúÖ³ÀàѬȾ΢ÉúÎïÉè¼Æ£¬Ò»´Î¼ì²âÍê³É¼¸Ê®ÖÖ²¡Ô­Î¢ÉúÎïɸ²é£¬°üÀ¨³£¼ûµÄHPVµÈ²¡Ô­Î¢ÉúÎ¸¨ÖúÁÙ´²ÕïÁÆ£¬¸üÖÜÈ«ÖúÁ¦¹¬¾±°©É¸²é¡£

 

ÏîÄ¿ÓÅÊÆ

1¡¢½ô¸ú¹²Ê¶

ÖлªÔ¤·Àҽѧ»áµÈȨÍþ»ú¹¹Ðû²¼×¨¼Ò¹²Ê¶£¬ÍƼö½«HPVºËËá¼ì²â×÷ΪÎÒ¹ú¹¬¾±°©É¸²éµÄÖ÷ÒªÒªÁì¡£

2¡¢×¼È·¶È¸ß

¶¨ÏòÔöÇ¿²¡Ô­ÐźÅ£¬È¥³ýÈËÔ´»ùÒò×é¼°Åä¾°¾ú»ùÒò×é×ÌÈÅ£¬Ñ¸Ëٶȸߣ¬ÌØÒì¶ÈºÃ¡£

3¡¢Ê±Ð§ÐÔ¸ß

¾Û½¹¸¾¿ÆÉúÖ³ÀàѬȾ²¡Ô­Ì壬ÔöÌíʱЧÐÔ£¬¸üºÃµÄ¸¨ÖúÁÙ´²¡£

 

Ó¦Óó¡¾°

?ÒõµÀÑ×»¼Õß

ÒõµÀÑ×ÖØ¸´±¬·¢£¬²¡Ô­²»Ã÷£¬ÖÎÁÆÐ§¹ûÇ·¼Ñ»¼Õß

?HPVѬȾ

Õë¶Ô¸ßΣ¡¢ÒÉËÆ¸ßΣ¡¢µÍΣÐÍHPV¼ì²â£¬¸¨Öú¹¬¾±°©¡¢ÉúÖ³Æ÷ðàµÄÔçÆÚɸ²é

?¸ßΣÐÔÐÐΪÈËȺ

¸ßΣÐÔÐÐΪÈËȺSTD¼ì²â£¬ÀýÈç÷¶¾ÂÝÐýÌå¡¢HIV¡¢Áܲ¡ÄÎɪ¾úµÈÐÔÈö²¥²¡Ô­ÌåѬȾ

?±¸ÔÐÈËȺ

±¸ÔÐǰ¶ÔÎÞÈéÁ´Çò¾ú¡¢CMVµÈ¿ÉÒýÆðĸӤ±ÊÖ±Èö²¥²¡Ô­Ìå¾ÙÐмì²â

 

ÊÊÓÃÈËȺ

? ³£¼û²¡Ô­ÌåѬȾ»¼Õß

? »ìÏýѬȾ»¼Õß

? ѬȾԵ¹ÊÔ­Óɲ»Ã÷»¼Õß

? ¹Å°å²¡Ô­¼ì²âÒõÐÔ»¼Õß

 

Ñù±¾ÒªÇó

¡ñ Å®ÐÔÒõµÀÊÃ×Ó

¡ñ ¹¬¾±ÍÑÂäϸ°û

¡ñ ÄòµÀÉøÍ¸Îï     

¡ñ ÉúÖ³µÀÉøÍ¸Îï

 

²Î¿¼ÎÄÏ×

[1]¡¶ÈËÈéÍ·×´Áö²¡¶¾ºËËá¼ì²âÓÃÓÚ¹¬¾±°©É¸²éÖйúר¼Ò¹²Ê¶£¨2022£©¡·.

[2] Schiffman, M.; Solomon, D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting. N. Engl. J. Med. 2013, 369, 2324–2331.

ÍøÕ¾µØÍ¼